Register your Account

Sign Up with us and Enjoy!
User nameEmailFirst NameLast NameContact info

A password will be e-mailed to you.

Big Stock Gainers (MAPP, LNET, CREE, THLD, SMCI)


NEW YORK, January 24,2013 (MESHPRESS) –  Beststocksdaily.com, an investment community with a  special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

MAP Pharmaceuticals Inc. (NASDAQ:MAPP) shares jumped 58.60% and closed at $24.71 after Allergan Inc said that it would buy MAP Pharmaceuticals Inc for about $958 million in cash, to deepen its presence in the treatment of migraines in adults. Under the deal, Allergan will acquire 100 percent of the shares of MAP Pharmaceuticals at $25 per share. MAP Pharmaceuticals is developing Levadex, an orally inhaled drug for the acute treatment of migraines in adults. Levadex is currently under review by the U.S. Food and Drug Administration.

Can MAPP Continue To Move Higher? Find Out Here

LodgeNet Interactive Corp. (PINK:LNET) shares gained 57.89% to $0.0300. The company, on Jan. 16, announced that Rich Battista will depart as President, CEO and director of the Company as of January 16, 2013. Frank Elsenbast, the Company’s CFO, and James Naro, the Company’s General Counsel, have been appointed interim co-CEOs. During his tenure, Battista successfully guided LodgeNet through a strategic review process that recently concluded with the announced $60 million recapitalization plan with an investor syndicate led by Colony Capital.

 Can LNET Extend Rally? Find Out Here

Cree, Inc. (NASDAQ:CREE) shares climbed 22.05% and closed at $40.85 after the company posted second quarter net income of $20.40 million or $0.18 per share, higher than $12.08 million or $0.10 per share in the prior-year quarter. Adjusted earnings for the quarter were $36.88 million or $0.32 per share, as compared to $28.67 million or $0.25 per share in the year-ago quarter. Net revenues grew 14% to $346.29 million from $304.12 million in the same quarter last year. Analysts expected earnings of $0.30 per on revenue of $331.20 million.

Can CREE Extend Jump? Find Out Here

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) shares increased 19.26% to $5.14 in yesterday’s session. Analysts at Piper Jaffray started coverage on shares of Threshold in a research report issued to clients and investors on Jan. 17. The firm set a “neutral” rating on the stock.

The company last announced its earnings results on Friday, November 2nd. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). The company had revenue of $1.80 million for the quarter, compared to the consensus estimate of $2.29 million.

Will THLD Bounce Back? Get Free Trend Analysis Here

Super Micro Computer, Inc. (NASDAQ:SMCI) shares gained 18.63% to $12.48. The company announced second quarter fiscal 2013 financial results for the quarter ended December 31, 2012. Net sales for the second quarter ended December 31, 2012 totaled $291.5 million, up 7.7% from $270.7 million in the first quarter of fiscal year 2013. Net income for the second quarter of fiscal year 2013 was $4.9 million or $0.11 per diluted share, a decrease of 44.0% from the net income of $8.8 million, or $0.20 per diluted share in the same period a year ago.

Will SMCI Bounce Back? Get Free Trend Analysis Here

About Beststocksdaily

Beststocksdaily.com team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily.com instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.

Disclaimer:

The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

beststocksdaily.com

staff@beststocksdaily.com

 

Related Press realease: